Illumina teases transcriptome profiling tech ahead of 2026 launch
Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a single spatial experiment.
20 February 2025
20 February 2025
Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a single spatial experiment.
The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.
CathVision is set to commence commercialisation in Europe in the upcoming quarters, building on its current US customer base.
BD has market-leading products in the IVD space, holding just under 20% of the sexual health tests market.
The acquisition brings together Inari's thrombectomy solutions with Stryker's neurovascular portfolio.
The AI neural network will help advance understanding of diseases and whole genomes.
Founded in 2005, IMRIS provides the only movable MRI that operates on a ceiling-mounted rail system.
LZH's device uses DNA-based sensors to provide real-time hormone monitoring.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.